User contributions for Publishedarticles

For Publishedarticles talk block log uploads logs global account filter log
A user with 79 edits. Account created on 17 August 2019.
Search for contributionsshowhide
⧼contribs-top⧽
⧼contribs-date⧽
(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

19 February 2024

16 February 2024

13 February 2024

11 February 2024

10 February 2024

7 February 2024

3 February 2024

30 January 2024

29 January 2024

  • 15:1715:17, 29 January 2024 diff hist +1,495‎ m Deep brain stimulation ‎ →‎Parkinson's disease: There are more than one hundred reported cases of DBS for Tourette syndrome in the literature. Approximately half of these patients received thalamic DBS (dorsomedial or centromedian-parafascicular complex), while around 40% had pallidal DBS (anteromedial globus pallidus internus, posteroventral globus pallidus internus, or a combination). The remaining cases involved DBS or either the anterior limb of the internal capsule/nucleus accumbens or the subthalamic nucleus. Tag: Visual edit

27 January 2024

  • 15:3815:38, 27 January 2024 diff hist +788‎ m Quinolone antibiotic ‎ →‎Nervous system: Rissardo et al. systematically reviewed the literature regarding movement disorders associated with fluoroquinolones. They found 51 cases who developed abnormal movements secondary to fluoroquinolones (ciprofloxacin, ofloxacin, gatifloxacin, moxifloxacin, levofloxacin, gemifloxacin, and pefloxacin). The movement disorders included myoclonus, dyskinesias, dystonia, cerebellar syndromes, ataxia, and tic. Tag: Visual edit

25 June 2023

  • 22:5822:58, 25 June 2023 diff hist +670‎ m Pregabalin ‎ →‎Adverse effects: 10.4103/bc.bc_57_19 In a systematic review of the literature about movement disorders secondary to pregabalin, the authors found 46 reports containing 305 cases. The abnormal movements found were ataxia, tremors, myoclonus, parkinsonism, restless legs syndrome, dystonia, dyskinesia, and akathisia. Tag: Visual edit

18 June 2023

14 June 2023

  • 21:5021:50, 14 June 2023 diff hist +744‎ Mirtazapine ‎ →‎Side effects: 10.4103/tcmj.tcmj_13_20 In a systematic review of the literature about movement disorders secondary to mirtazapine, fifty-two reports containing 179 cases were assessed. The abnormal movements encountered were restless legs syndrome, tremors, akathisia, periodic limb movement disorder, dystonia, rapid eye movement sleep behavior disorder, dyskinesia, parkinsonism, and tic. Tag: Visual edit

5 June 2023

  • 18:5018:50, 5 June 2023 diff hist +837‎ Flunarizine ‎ →‎Side effects: 10.1186/s41983-020-00197-w In a systematic review of the literature about cinnarizine- and flunarizine-associated movement disorders. The authors found one hundred seventeen reports containing 1920 individuals who developed an abnormal movement secondary to these drugs. The movement disorders encountered were parkinsonism, dyskinesias, akathisia, dystonia, myoclonus, extrapyramidal symptoms, tremors, bradykinesia, and myokymia. Tag: Visual edit

31 May 2023

  • 21:0221:02, 31 May 2023 diff hist +766‎ m Carbamazepine ‎ →‎Adverse effects: 10.1097/WNF.0000000000000387. In a systematic review, the authors identified seventy-three reports containing one-hundred ninety-one individuals who developed movement disorders associated with carbamazepine, oxcarbazepine, and eslicarbazepine. The abnormal movements encountered were myoclonus, dystonia, tics, dyskinesia, parkinsonism, akathisia, and unclear incoordination. Tag: Visual edit

30 May 2023

  • 00:1000:10, 30 May 2023 diff hist +797‎ m Lithium (medication) ‎ →‎Adverse effects: In a systematic literature review, the authors found 250 reports containing 1100 individuals who developed lithium-related movement disorders. The abnormal movements encountered were parkinsonism, dyskinesia, myoclonus, dystonia, Creutzfeldt-Jakob-like syndrome, akathisia, restless legs syndrome symptoms, tics, cerebellar syndromes, and stuttering. Tag: Visual edit

23 May 2023

  • 22:3122:31, 23 May 2023 diff hist +787‎ m Rimegepant ‎ →‎History: The favorable results of rimegepant’s first clinical trials were followed by ongoing studies with other gepants. In this way, the second generation of gepants emerged, and it includes rimegepant (BHV-3000, BMS-927711), ubrogepant (MK-1602), and atogepant (AGN-241689, MK-8031. These drugs revealed a low number of side effects, with excellent bioavailability due to molecular modifications Tag: Visual edit
  • 00:5800:58, 23 May 2023 diff hist +653‎ m Phenytoin ‎ →‎Neurological: In a systematic review, 219 individuals who developed movement disorders associated with phenytoin were encountered. The abnormal movements reported with phenytoin were dyskinesias, myoclonus, dystonia, parkinsonism, tics, stuttering, and restless legs syndrome. Tag: Visual edit
  • 00:5100:51, 23 May 2023 diff hist +943‎ m Pimavanserin ‎ →‎Research: Comparison of pimavanserin and other antipsychotics. Also, the risk of falls was assessed. Tag: Visual edit

22 February 2022

  • 12:0812:08, 22 February 2022 diff hist +616‎ m Lamotrigine ‎ →‎Side effects: A systematic review of the literature revealed that abnormal movements secondary to lamotrigine are uncommon. The movement disorders associated with lamotrigine were tics, akathisias, dyskinesias, myoclonus, parkinsonism, dystonia, cerebellar syndromes, and stuttering. Tag: Visual edit

26 November 2021

17 November 2021

15 November 2021

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://en.wikipedia.org/wiki/Special:Contributions/Publishedarticles"